GURU.Markets stock price, segment price, and overall market index valuation
The company's share price USBC Inc
The stock price of U.S. Bancorp, one of the largest banks in the United States, is a barometer of the American economy. Its trajectory depends on the Federal Reserve's interest rate policy, corporate and consumer demand for credit, and the quality of its vast loan portfolio.
Share prices of companies in the market segment - Holding
USBC Inc. (formerly Know Labs) develops non-invasive diagnostic technologies, specifically biosensors capable of measuring blood glucose levels without puncturing the skin. We classify it as a "Holding." The chart below shows the dynamics of the advanced diagnostics sector in which it operates.
Broad Market Index - GURU.Markets
U.S. Bancorp is one of the largest bank holding companies in the United States, providing a full range of financial services nationwide. As part of the GURU.Markets index, it serves as a barometer for the entire American economy. The chart below represents the entire market. See how this giant compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
USBC - Daily change in the company's share price USBC Inc
The daily price change of USBC Inc., a technology-focused holding company, reflects speculative interest in its developments. Change_co measures the high volatility associated with patent and research news. This metric is an important element for analyzing venture-backed tech companies on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Holding
The holding company sector in which USBC Inc operates is highly diverse. This chart reflects the average volatility of the industry. It serves as a benchmark for assessing how sensitive USBC's business is to overall trends, the investment climate, and competition.
Daily change in the price of a broad market stock, index - GURU.Markets
Know Labs (the parent company of USBC) is developing a non-invasive glucose monitoring technology. This is a potentially revolutionary technology in medicine. The chart below shows the volatility in the medical device sector, reflecting the enormous expectations and risks associated with the parent company's developments.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization USBC Inc
The year-over-year performance of USBC Inc., which operates through the Know Labs brand, is a story about the development of a noninvasive glucometer. Its 12-month market cap depends entirely on progress in the development and testing of its device, which uses radiofrequency technology. A successful demonstration of accuracy will be a fundamental breakthrough for millions of diabetics.
Annual dynamics of market capitalization of the market segment - Holding
Know Labs is developing a non-invasive glucose monitoring technology. Its performance is entirely speculative and depends on investors' faith in its breakthrough potential. The chart shows how news about clinical trials and partnerships can cause sharp fluctuations, which is unusual for the broader medical device sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
The USBC ticker belongs to U.S. Bancorp, not USBC Inc. The website is owned by Know Labs (KNW). Know Labs, with its noninvasive glucose monitoring technology, is highly speculative. Its stock performance reflects not economics but investor faith in a technological breakthrough.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization USBC Inc
USBC's value as a holding company will reflect the value of its assets. Monthly fluctuations on the chart will represent the combined performance of its subsidiaries and the valuation of its investments in various sectors of the economy.
Monthly dynamics of market capitalization of the market segment - Holding
The speculative medical technology market, particularly in non-invasive diagnostics, is fueled by anticipation of breakthroughs. The chart below reflects the high volatility and dependence on R&D news. In this environment, where scientific data, not profits, rules, companies like Know Labs are pursuing risky developments.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
USBC Inc. appears to be a holding company. The stock performance of such entities is the sum of the performance of their subsidiaries. This can smooth out market fluctuations or, conversely, lead to unique movements if the assets are concentrated in a single niche.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization USBC Inc
USBC Inc., as a holding company, may hold a variety of assets. Its weekly performance reflects the combined performance of its subsidiaries. Its reaction to news depends on which business segment is key and what events are occurring within it.
Weekly dynamics of market capitalization of the market segment - Holding
Investment holdings like USBC represent a diversified bet across several sectors. Their performance depends on the overall economic situation. The chart below shows the average performance by sector. It allows one to assess how successfully USBC manages its asset portfolio compared to other similar companies.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
USBC Inc (Know Labs) is developing a non-invasive technology for monitoring blood glucose levels using radio waves. It's the "holy grail" of diabetes treatment. The chart below will show how much its stock is a speculative bet on a single technology, completely disconnected from market reality.
Market capitalization of the company, segment and market as a whole
USBC - Market capitalization of the company USBC Inc
The market capitalization chart of USBC Inc. (operating as Know Labs) reflects investors' bets on its breakthrough noninvasive glucose monitoring technology. The chart reflects the market's belief that its radiofrequency sensor will change the lives of millions of diabetics. Its high volatility and price reflect its enormous potential, coupled with a high risk of clinical failure.
USBC - Share of the company's market capitalization USBC Inc within the market segment - Holding
USBC Inc., operating under the brand name Know Labs, develops non-invasive glucose monitoring technologies. Classified as a holding company, its true core lies in biomedical innovation. Its market capitalization reflects the enormous expectations of creating the "Holy Grail" for diabetics—the ability to measure blood sugar without pricking a finger.
Market capitalization of the market segment - Holding
This chart shows the total market capitalization of all investment holdings. For USBC Inc. (Know Labs), which is developing a non-invasive glucometer, this classification is misleading. The real context for it is the trillion-dollar diabetes market. The holdings chart's dynamics don't reflect the revolutionary potential that investors see in its technology.
Market capitalization of all companies included in a broad market index - GURU.Markets
USBC Inc. is a holding company with various assets. Its market capitalization is the combined value of its subsidiaries. It is an example of a diversified company whose value depends on success in various, unrelated areas.
Book value capitalization of the company, segment and market as a whole
USBC - Book value capitalization of the company USBC Inc
USBC Inc. (Know Labs) develops non-invasive diagnostic sensors, such as those for measuring glucose levels. Its book value is its scientific capital: patents for Bio-RFID technology and R&D equipment. This is the material basis for a revolution in diagnostics. How has this capital changed? The chart below shows.
USBC - Share of the company's book capitalization USBC Inc within the market segment - Holding
USBC Inc., through its subsidiary Know Labs, develops non-invasive diagnostic technologies. Its assets are not factories, but advanced R&D labs equipped with radiofrequency equipment for creating next-generation sensors. The chart shows its share of the physical infrastructure for developing breakthrough medical devices.
Market segment balance sheet capitalization - Holding
USBC Inc (Know Labs), working in the field of non-invasive diagnostics, has a lightweight R&D business. The company is focused on developing its Bio-RFID technology. The BCap_Seg chart for the biotech sector, which is full of R&D companies, confirms that at this stage, the most important capital is intellectual capital.
Book value of all companies included in the broad market index - GURU.Markets
USBC Inc. (Know Labs)'s capital isn't its factories, but its research labs and a portfolio of patents for noninvasive radiofrequency glucose monitoring technology. Its assets are capitalized science. The chart shows how this intangible yet groundbreaking R&D asset stacks up against the medtech giants.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - USBC Inc
USBC (Know Labs)'s balance sheet is its R&D capital. Its entire enormous market value is a premium on the hope of creating the world's first non-invasive glucometer. The chart is a bet on a technology that could change the lives of hundreds of millions of diabetics.
Market to book capitalization ratio in a market segment - Holding
USBC Inc is a holding company. Its valuation on this chart will reflect how investors perceive the value of its diverse assets and the synergies between them, as well as management's ability to effectively manage this portfolio to create shareholder value.
Market to book capitalization ratio for the market as a whole
USBC Inc. (Know Labs) develops non-invasive diagnostic technologies, such as glucose monitoring. Its market value is based solely on the potential of its technology. This chart clearly demonstrates the extreme discrepancy between book value and market valuation for science-based startups.
Debts of the company, segment and market as a whole
USBC - Company debts USBC Inc
USBC Inc., a holding company, uses its structure to own and manage various assets. Debt policy at the holding level depends on the strategy and needs of its subsidiaries. This chart shows how the company manages capital at the corporate level to finance its investments and operations.
Market segment debts - Holding
USBC Inc. (Know Labs) is developing a non-invasive radiofrequency-based blood glucose monitoring technology. This is a breakthrough, but highly complex technology. This chart shows that the company, which is in the R&D stage, is financed exclusively through equity, as debt is unaffordable for such risky projects.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio USBC Inc
USBC Inc. is a holding company, and its financial structure depends on the assets it owns. This chart shows the holding company's overall debt load. It helps investors understand how aggressive its strategy for acquiring and managing subsidiaries is, and what risks this creates for the entire corporate structure.
Market segment debt to market segment book capitalization - Holding
USBC Inc., operating under the brand name Know Labs, is developing a non-invasive radiofrequency-based blood glucose monitoring technology. It's the "holy grail" for diabetics. The chart shows debt trends in the sector, illustrating the enormous investment required to achieve such a technological breakthrough.
Debt to book value of all companies in the market
USBC Inc. (Know Labs), working on noninvasive glucose monitoring technology, is at the forefront of medical innovation, requiring significant investment in R&D. This chart, showing the market's overall debt load, allows one to assess how the company's financial strategy aligns with its status as a high-tech venture.
P/E of the company, segment and market as a whole
P/E - USBC Inc
USBC Inc. is a holding company that invests in and develops technologies across various fields. This chart shows how the market values its innovation portfolio. The dynamics reflect investors' belief in the potential of its subsidiaries and technologies that may be in the early stages of development.
P/E of the market segment - Holding
USBC Inc. is a holding company investing in technology. This chart shows the average valuation for diversified holding companies. It helps us understand whether USBC is trading at a discount typical for conglomerates, or whether investors believe its management can create value greater than the sum of its parts.
P/E of the market as a whole
USBC Inc., formerly known as Know Labs, develops non-invasive diagnostic technologies, specifically for blood glucose monitoring using radiofrequency spectroscopy. This chart reflects investors' overall risk appetite. It helps us understand whether USBC's high valuation is based on faith in its breakthrough technology or is driven by overall biotech sentiment.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company USBC Inc
USBC Inc. is a holding company with diverse interests. Its future profits depend on the success of its subsidiaries across various industries. This chart reflects aggregate market expectations regarding the prospects of its diversified asset portfolio and the effectiveness of its management.
%20P%2FE%20USBC%20Inc&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-USBC-Inc&v=1772513536604 "Chart of the company's future (projected) P/E USBC Inc")
Future (projected) P/E of the market segment - Holding
USBC Inc. (through Know Labs) is developing a non-invasive blood glucose monitoring technology using radiofrequency sensors. This graph reflects its future profitability expectations, betting on a breakthrough in one of the most coveted areas of medical technology—the "Holy Grail" of diabetes.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Holding&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Holding&v=1772513536609 "Future (projected) P/E graph of the market segment - Holding")
Future (projected) P/E of the market as a whole
USBC Inc. (operating as Know Labs) is developing non-invasive blood glucose monitoring technology. It's the Holy Grail for diabetics. This sentiment chart shows how willing investors are to invest in breakthrough technologies that haven't yet proven commercial viability.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513536647 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit USBC Inc
USBC Inc. (Know Labs) is a company developing non-invasive blood glucose monitoring technology using radiofrequency. This chart shows the massive investment in creating the "Holy Grail" for diabetics. It reflects not profits, but rather the costs of research that, if successful, could revolutionize medicine.
Profit of companies in the market segment - Holding
USBC Inc., through Know Labs, develops non-invasive diagnostic technologies, specifically a glucometer that can measure blood sugar levels without piercing the skin. This represents a potential breakthrough in diabetes treatment. The company's future profitability depends entirely on the success of this cutting-edge and sophisticated technology.
Overall market profit
USBC Inc (Know Labs) is a company developing a non-invasive radiofrequency-based blood glucose monitoring technology. Its valuation depends entirely on the success of this breakthrough development. The overall economic situation, reflected in this chart, does not directly impact the demand for such a device, but it does influence the availability of capital for its development and launch.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company USBC Inc
USBC Inc., operating as Know Labs, is developing a non-invasive radiofrequency blood glucose monitoring technology. This chart reflects highly speculative analyst expectations. Future profits are entirely dependent on the successful development, clinical validation, and approval of this breakthrough technology.
%20profit%20of%20the%20company%20USBC%20Inc&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-USBC-Inc&v=1772513536946 "Graph of future (projected) profit of the company USBC Inc")
Future (predicted) profit of companies in the market segment - Holding
USBC Inc. is a holding company with diverse interests. The profitability projections for investment holdings, reflected in this chart, depend on the performance of their subsidiaries and the overall economic environment. This chart helps investors assess the diversification and effectiveness of the company's asset portfolio.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Holding&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Holding&v=1772513537045 "Graph of future (predicted) profits of companies in a market segment - Holding")
Future (predicted) profit of the market as a whole
USBC Inc. is a holding company that invests in various technologies. The prospects of these companies depend on the success of their portfolio investments and the overall state of the venture capital market. A positive economic environment, reflected in this chart, creates more favorable conditions for growth and exits.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513537067 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - USBC Inc
USBC Inc., through its subsidiary Know Labs, develops non-invasive glucose monitoring technologies. The company may not have commercial revenue. This chart shows the huge premium investors are paying for its potential, betting that its technology will revolutionize diabetes treatment by eliminating finger pricks.
P/S market segment - Holding
USBC Inc. (operating as Know Labs) develops non-invasive diagnostic technologies, specifically sensors for continuous blood glucose monitoring without puncturing the skin. This figure reflects the average revenue estimate for the sector and helps understand the significant market premium that could be commanded for a breakthrough technology in diabetes treatment.
P/S of the market as a whole
USBC Inc. (formerly Know Labs) is a holding company focused on developing noninvasive diagnostic technologies, specifically a glucometer that can measure blood sugar levels without piercing the skin. This chart shows how the market values companies with established revenues, which is important for contextualizing the analysis of disruptive technology companies.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company USBC Inc
USBC Inc. is a holding company with diverse interests, including technology. This chart reflects how investors estimate the future returns of its asset portfolio. This valuation depends on the success of its subsidiaries and management's ability to effectively allocate capital across various projects.
%20P%2FS%20USBC%20Inc&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-USBC-Inc&v=1772513537153 "The graph of the company's future (projected) P/S USBC Inc")
Future (projected) P/S of the market segment - Holding
USBC Inc. is a holding company that invests in various businesses. This chart compares the company's estimated future earnings with other holding companies. It reflects how investors view its asset portfolio and management's ability to identify and develop profitable businesses, generating shareholder value, compared to peers.
%20P%2FS%20market%20segment%20graph%20-%20Holding&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Holding&v=1772513537160 "Future (projected) P/S market segment graph - Holding")
Future (projected) P/S of the market as a whole
USBC Inc. is a holding company focused on various technology and business areas. Its performance may be diversified and dependent on the success of its individual subsidiaries. This graph of USBC's overall growth expectations serves as a backdrop, while its true value is determined by the effectiveness of its asset portfolio management.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513537201 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales USBC Inc
This chart shows USBC Inc.'s revenue (likely an error; the ticker symbol may refer to a different company). Assuming this is a holding company, its revenue could be derived from the earnings of its subsidiaries in various industries. The dynamics will depend on the success of each business line and the holding company's overall strategy for managing its assets.
Sales of companies in the market segment - Holding
USBC Inc. is a holding company that invests in various technologies and businesses, striving to create shareholder value through the strategic management of its assets. This chart shows the holding company's earnings. It reflects the overall economic environment and USBC management's ability to identify and develop promising projects within its diversified portfolio.
Overall market sales
USBC Inc. is a holding company that can engage in a variety of activities. Its relationship to the overall economy depends on the specific assets in its portfolio. If these are industrial or consumer businesses, their performance will correlate with this chart. If these are countercyclical assets, the relationship may be the opposite.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company USBC Inc
USBC Inc., operating as Know Labs, is developing a breakthrough non-invasive blood glucose monitoring technology. This revenue projection is purely speculative. Its growth reflects analysts' confidence in the company's ability to successfully complete development, secure regulatory approval, and commercialize this life-changing technology.
%20sales%20of%20the%20company%20USBC%20Inc&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-USBC-Inc&v=1772513537319 "Schedule of future (projected) sales of the company USBC Inc")
Future (projected) sales of companies in the market segment - Holding
USBC Inc. is a holding company that can own various assets or businesses. Such structures are often used for mergers, acquisitions, or to manage a diversified portfolio. This chart shows projected returns for the entire holding sector, reflecting the overall economic conditions that influence asset prices and returns.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Holding&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Holding&v=1772513537337 "Schedule of future (projected) sales of companies in the market segment - Holding")
Future (projected) sales of the market as a whole
USBC Inc. (Know Labs) is developing noninvasive glucose monitoring technologies. The company's success depends on a technological breakthrough and regulatory approval. The overall economic climate impacts the availability of venture capital, which is necessary to finance such long-term and risky R&D projects.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513537376 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality USBC Inc
USBC Inc., now known as Know Labs, is developing noninvasive glucose monitoring technology. As a company in the R&D stage, it does not yet generate significant revenue. This chart illustrates the extent of its investment in breakthrough technology, showing operating losses as the price of future commercial opportunities in the vast diabetes market.
Market segment marginality - Holding
USBC Inc., through its subsidiary Know Labs, develops non-invasive diagnostic technologies, specifically for measuring blood glucose levels. This chart reflects its financial performance. For a company developing a breakthrough technology, profitability is not a key metric, but it does demonstrate the effectiveness of R&D cost management.
Market marginality as a whole
USBC Inc. appears to be a holding company with diverse interests. For such companies, it's difficult to establish a direct correlation with overall profitability. Their success depends on effectively managing a portfolio of subsidiaries operating in different sectors, each of which reacts differently to economic cycles.
Employees in the company, segment and market as a whole
Number of employees in the company USBC Inc
USBC Inc. appears to be a holding company or a speculative venture. The minimal team size likely shown in this chart suggests it may be a company without significant operating activity or a company in the very early stages of identifying its business model.
Share of the company's employees USBC Inc within the market segment - Holding
USBC Inc. (Know Labs) is a development-stage company working on noninvasive glucose monitoring technology. Its team consists of a small group of scientists and engineers. This graph illustrates its current status: its minimal staff means all its value is focused on the potential of its breakthrough technology.
Number of employees in the market segment - Holding
USBC Inc., through its subsidiary Know Labs, develops noninvasive glucose monitoring technologies. This graph shows the early stages of development of a breakthrough medical device. A small team of scientists and engineers is working to solve one of the most complex problems in diabetes care. Success will lead to explosive growth, but the risks are high.
Number of employees in the market as a whole
USBC Inc., operating as Know Labs, is developing non-invasive blood glucose monitoring technology. Its small staff consists of scientists and engineers. This employment chart demonstrates that companies working on breakthrough technologies have the potential to transform entire industries, and their early-stage growth is driven not by economics but by scientific advancement and funding.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company USBC Inc (USBC)
USBC Inc. appears to be a holding company, possibly linked to Know Labs, which develops non-invasive glucose monitoring sensors. If so, it's an R&D company. This chart would show a huge per-employee value, as the market cap reflects investors' faith in the breakthrough technology, not current operations.
%20of%20the%20company%20USBC%20Inc%20(USBC)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-USBC-Inc-USBC&v=1772513537611 "Chart of market capitalization per employee (in thousands of dollars) of the company USBC Inc (USBC)")
Market capitalization per employee (in thousands of dollars) in the market segment - Holding
USBC Inc. is a holding company that, through its subsidiaries, develops technologies, particularly in the field of biometric sensors. This indicator reflects investors' confidence in the technological potential of the holding's assets. A high value may indicate that the market values the intellectual property created by a small team of engineers.
%20by%20market%20segment%20-%20Holding&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Holding&v=1772513537644 "Market capitalization per employee (in thousands of dollars) by market segment - Holding")
Market capitalization per employee (in thousands of dollars) for the overall market
USBC Inc. is a holding company investing in various technologies. This metric reflects the venture capital model. The company's value is the sum of the valuations of its investments, which are managed by a very small team. This results in a high but highly volatile market capitalization per employee.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513537657 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company USBC Inc (USBC)
USBC Inc (Know Labs) is an R&D company developing a non-invasive glucose monitoring technology (a sensor that doesn't require a puncture). They are not profitable. This graph shows the loss per employee. This is the cost of "burning" capital on R&D in an attempt to create a revolutionary medical device.
%20Chart%20USBC%20Inc%20(USBC)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-USBC-Inc-USBC&v=1772513537659 "Company Profit Per Employee (in thousands of dollars) Chart USBC Inc (USBC)")
Profit per employee (in thousands of dollars) in the market segment - Holding
U.S. Bancorp (USB) is one of the largest and most diversified banks in the United States. (The ticker symbol "USB" is more important than the misnomer in the data.) This metric reflects average labor productivity across a massive organization spanning retail banking, commercial lending, asset management, and payment services.
%20in%20the%20market%20segment%20-%20Holding&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Holding&v=1772513537661 "Chart of profit per employee (in thousands of dollars) in the market segment - Holding")
Profit per employee (in thousands of dollars) for the market as a whole
USBC Inc. (operating as Know Labs) is a company developing non-invasive diagnostic sensors (e.g., a puncture-free glucose meter). They are in the R&D stage. This chart doesn't show profit. It shows capital burn: the negative per-employee ratio reflects the high cost of the team of physicists and engineers working to create this breakthrough technology.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513537684 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee USBC Inc (USBC)
USBC Inc. is a holding company that invests in various businesses. The chart reflects a diversified and opportunistic model. Revenue per employee dynamics can be volatile and depend on the financial performance of its portfolio companies, rather than on a single operating process.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-USBC-Inc-USBC&v=1772513537740 "Sales chart per company employee USBC Inc (USBC)")
Sales per employee in the market segment - Holding
USBC Inc (USBC) (likely related to Know Labs) is a company developing noninvasive diagnostic technologies, specifically a noninvasive glucose monitor (Bio-RFID). This chart shows the revenue (if any) generated by each employee (engineer). It reflects the R&D stage and progress toward commercialization of their cutting-edge diagnostic technology.
Sales per employee for the market as a whole
USBC Inc (Know Labs) is a company developing a noninvasive glucose monitoring technology (Bio-RFID™). It is an early-stage R&D company and has no commercial revenue from its product. This metric, close to zero, does not reflect current operating activities, but rather research expenses.
Short shares by company, segment and market as a whole
Shares shorted by company USBC Inc (USBC)
Know Labs (KNW) is a company trying to create a non-invasive glucometer using radiofrequency technology. This chart shows bearish bets. The bears are betting that the technology won't work. Creating an accurate non-invasive glucometer is the "Holy Grail" of medical technology, where many giants have failed.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-USBC-Inc-USBC&v=1772513537772 "Short Shares Chart for the Company USBC Inc (USBC)")
Shares shorted by market segment - Holding
Know Labs (USBC/KNW) is a company trying to create the "Holy Grail" of diabetes: a non-invasive (no finger-prick) glucometer. This metric measures pessimism. The "short" here is a bet that their "Bio-RFID" technology won't work. Many have tried, but no one has yet succeeded.
Shares shorted by the overall market
USBC Inc (Know Labs) is a company developing non-invasive sensors, such as those for measuring blood glucose levels without piercing. This is a breakthrough technology. This chart measures overall market fear. When investors panic, they often sell shares of "future" companies that don't yet have a product on the market, preferring to make real profits here and now.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator USBC Inc (USBC)
USBC Inc (USBC) (likely Know Labs, KNOW) is a company developing non-invasive glucose monitoring technology (Bio-RFID). They are aiming to create a sensor that measures blood sugar without piercing it. This is a speculative R&D bet. This chart measures hype. It shows "overheated" (above 70) on positive test news or "oversold" (below 30) amid delays.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-USBC-Inc-USBC&v=1772513537827 "RSI 14 indicator chart for the company's stock USBC Inc (USBC)")
RSI 14 Market Segment - Holding
USBC Inc (Knowlabs) is a high-tech company in the medical field. They develop *non-invasive* sensors (Bio-RFID) for *continuous* glucose monitoring (without piercing). RSI_14_Seg for their segment (medtech) shows the "temperature." It helps us understand: is USBC's volatility just hype or is the entire sector overheated?
RSI 14 for the overall market
USBC (Knowlabs) is pure hype. This chart demonstrates the appetite for speculation. During periods of market euphoria, investors are ready to "buy the dream" and invest in any company related to "AI" and "bio." During moments of panic, investors flee unprofitable "concepts," and these stocks are the first to be sold off.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast USBC (USBC Inc)
USBC (Know Labs) is a company developing non-invasive diagnostic technology called Bio-RFID. Their primary goal is to create the first non-invasive glucose monitor. This chart shows the average 12-month analyst forecast. Their target price is a highly speculative bet on clinical trial success and FDA approval.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-USBC-USBC-Inc&v=1772513537899 "A chart showing analyst consensus forecasts for the expected stock price. USBC (USBC Inc)")
The difference between the consensus estimate and the actual stock price USBC (USBC Inc)
Know Labs (USBC) is a bet on a technological breakthrough. The company is developing a non-invasive glucometer (Bio-RFID) that could change the lives of diabetics. This chart shows how far the current stock price differs from the "fair" value predicted by analysts. The gap reflects their faith (or skepticism) in this breakthrough, yet unproven, technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-USBC-USBC-Inc&v=1772513537980 "A chart showing the difference between the consensus forecast and the actual stock price. USBC (USBC Inc)")
Analyst consensus forecast for stock prices by market segment - Holding
USBC Inc. (Know Labs) is a venture capital firm seeking to revolutionize diagnostics using Bio-RFID technology. Their "holy grail" is a non-invasive glucometer. This chart shows general expectations for the holding and MedTech sectors. It reflects whether experts believe in the commercialization of breakthrough but risky technologies.
Analysts' consensus forecast for the overall market share price
Know Labs (formerly USBC) is working on the "holy grail" of diagnostics: non-invasive glucose monitoring (no need to puncture a blood glucose meter). They are developing Bio-RFID technology. This chart shows the overall risk appetite. For Know Labs, a development-stage company whose value is pure expectation, overall market optimism (risk appetite) is critical to funding multi-year R&D.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index USBC Inc
USBC (Know Labs) is an R&D company working on the holy grail of diabetes treatment: a noninvasive glucose monitor. Their Bio-RFID technology uses radio frequencies to measure blood sugar levels without a finger prick or implant. This chart is a pure indicator of faith in their technology. It doesn't reflect revenue, but rather a speculative assessment of their R&D progress and their chances of clinical and regulatory success.
AKIMA Market Segment Index - Holding
Know Labs (USBC) is an early-stage R&D company pursuing the Holy Grail of diabetes: a non-invasive (puncture-free) glucose monitor using its proprietary Bio-RFID technology. This comprehensive index ranks companies. The chart shows the sector average. This benchmark allows one to assess how this futuristic (and speculative) R&D focus differentiates Know Labs from its average medtech competitor.
The AKIM Index for the overall market
USBC (Know Labs) is a company developing non-invasive medical diagnostics, including blood glucose monitoring using radio waves. This chart, which reflects the market average, is a backdrop. It helps assess how this speculative early-stage tech story fits into the overall macroeconomic picture.
